Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early steroid withdrawal after Thymoglobulin induction in kidney transplantation
NCT02447822Phase 4Unknown
- Sponsor
- Asan Medical Center
- Start
- Jun 2015
- Primary completion
- May 2018
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 4 trial of antithymocyte globulin in kidney failure (ESRD), sponsored by Asan Medical Center. Status: unknown.
02
Drugs
antithymocyte globulin
03
Conditions
kidney failure (ESRD)
Beyond the preview
Go deeper on NCT02447822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02447822.